Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial
Clinical trial NCT04602065 · TERMINATED
Trial details
- NCT number
- NCT04602065
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2023-02-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.